Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lundberg

Showing results (411-420 of 463) with videos related to

Pageof 47
Sort By:
Annals of the Rheumatic Diseases|December 22, 2011
Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case studyH Chinoy, S Adimulam, F Marriage, et al.
Cellular & Molecular Immunology|December 5, 2019
Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responsesRyan A Adams, Cátia Fernandes-Cerqueira, Antonella Notarnicola, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2024
Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021Anna L V Johansson, Simon M Kønig, Siri Larønningen, et al.
Annals of Neurology|March 6, 2013
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositisHelma Pluk, Bas J A van Hoeve, Sander H J van Dooren, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathiesM Jani, J Massey, L R Wedderburn, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Annals of the Rheumatic Diseases|February 26, 2015
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseasesMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.
Seminars in Arthritis and Rheumatism|August 23, 2024
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international networkFabricio Espinosa-Ortega, Karin Lodin, Maryam Dastmalchi, et al.
Pageof 47

Showing results (411-420 of 463) with videos related to

Sort By:
Pageof 47
Annals of the Rheumatic Diseases|December 22, 2011
Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case studyH Chinoy, S Adimulam, F Marriage, et al.
Cellular & Molecular Immunology|December 5, 2019
Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responsesRyan A Adams, Cátia Fernandes-Cerqueira, Antonella Notarnicola, et al.
Acta Oncologica (Stockholm, Sweden)|April 10, 2024
Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021Anna L V Johansson, Simon M Kønig, Siri Larønningen, et al.
Annals of Neurology|March 6, 2013
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositisHelma Pluk, Bas J A van Hoeve, Sander H J van Dooren, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathiesM Jani, J Massey, L R Wedderburn, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Annals of the Rheumatic Diseases|February 26, 2015
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseasesMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.
Seminars in Arthritis and Rheumatism|August 23, 2024
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international networkFabricio Espinosa-Ortega, Karin Lodin, Maryam Dastmalchi, et al.
Pageof 47